| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|---|
| Research and development | $184.7M+54.6% | $119.4M+5.0% | $113.8M+1.1% | $112.5M+12.4% | $100.1M+103.1% | $49.3M |
| General and administrative | $31.7M-8.4% | $34.6M+15.5% | $30.0M-9.5% | $33.1M+8.0% | $30.6M+115.9% | $14.2M |
| Total operating expenses | $216.4M+40.5% | $154.1M+7.2% | $143.7M-1.3% | $145.6M+11.4% | $130.7M+105.9% | $63.5M |
| Loss from operations | -$216.4M-40.5% | -$154.1M-7.2% | -$143.7M+1.3% | -$145.6M-11.4% | -$130.7M-105.9% | -$63.5M |
| Interest and other income, net | $9.7M-38.8% | $15.9M+67.3% | $9.5M+159.7% | $3.7M+836.4% | $390K+584.2% | $57K |
| Net loss | -$206.7M-49.6% | -$138.2M-3.0% | -$134.2M+5.4% | -$141.9M-8.9% | -$130.3M-105.5% | -$63.4M |
| Deemed dividend on modification of common stock warrants | -$1.9M | $0 | — | — | — | — |
| Net loss attributable to common stockholders | -$208.5M-50.9% | -$138.2M | — | — | -$130.3M-85.3% | -$70.3M |
| Net loss per share, basic | -$1340.00-32.7% | -$1010.00+42.9% | -$1770.00+31.9% | -$2600.00+23.5% | -$3400.00 | — |
| Net loss per share, diluted | -$1340.00-32.7% | -$1010.00+42.9% | -$1770.00+31.9% | -$2600.00+23.5% | -$3400.00 | — |
| Weighted-average shares used in computing net loss per share, basic | $155105832000.00+12.9% | $137404145000.00+81.6% | $75673081000.00+38.4% | $54673572000.00+42.7% | $38316273000.00 | — |
| Weighted-average shares used in computing net loss per share, diluted | $155105832000.00+12.9% | $137404145000.00+81.6% | $75673081000.00+38.4% | $54673572000.00+42.7% | $38316273000.00 | — |
Source: SEC EDGAR XBRL. % change vs prior period shown where available.
Source: SEC EDGAR 10-K and 10-Q filings. Up to 10 years annual / 16 quarters shown.